In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

GSK is carving out a niche for Blenrep in the second-line multiple myeloma setting, for which it projects a multi-blockbuster ...

In its new lawsuit, Ben & Jerry’s says that Unilever has breached ... said he was concerned about the “continued perception of anti-Semitism” regarding the ice cream brand voicing its opinions on ...

For the past three years, biotechs and pharmas have renamed, rebranded and more in a bid to refresh their corporate appeal. ...

Starting this November, Winther will lead the agency’s 20-plus member creative team. In his new role, Winther will drive ...

GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...

Kruti Berawala examines Tata’s decision to merge Vistara into Air India, a move that seeks to blend Air India’s legacy with ...

A Birmingham-based advertising and marketing agency has tapped a new C-suite leader. Mark Unrein is the new chief AI officer for Luckie & Co. He will split his time between the company's Birmingham ...

UAB St. Vincent's is the new name for the five-hospital system that Birmingham-based UAB Medicine acquired Nov. 1 from St. Louis-based Ascension. The deal, which combines a $2.5 billion system with a ...

Under his leadership, the North office was responsible for numerous global and Indian brands like, PepsiCo, Nestle, GSK, Hero ...

Luckie & Co. has announced the appointment of Mark Unrein to Chief AI Officer (CAIO). In this new role for the company, Mark ...

Health Canada has granted approval for GlaxoSmithKline ... new treatments." "Health Canada approves GSK’s Ojjaara for ...